Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/7/2025

Motor System Distinctions

Clinical Manifestations

  • The American Academy of Neurology notes that extrapyramidal dysfunction manifests as hypomimia, muscular rigidity, bradykinesia, hypokinesia, monotonous and slow speech, parkinsonian-like tremor, and dyskinesia with diminished voluntary movements 1, 2, 3
  • The European Academy of Neurology emphasizes that pyramidal tract involvement is characterized by hypertonia, hyperreflexia, and positive Babinski sign 1
  • Pyramidal system manifestations include progressive spasticity and weakness, particularly affecting extensors in the upper limbs and flexors in the lower limbs, indicating upper motor neuron pathology originating from the corticospinal tract 1

Clinical Context

  • The American College of Radiology notes that Multisystem Atrophy (MSA) demonstrates both pyramidal signs (hyperreflexia) and extrapyramidal features (parkinsonism present in 87% of cases), making it a "Parkinson-plus" syndrome 5
  • In Hepatic Encephalopathy, pyramidal signs include hypertonia, hyperreflexia, and positive Babinski, while extrapyramidal signs include the full spectrum of parkinsonian features 1, 2, 3, 4

Diagnostic Considerations

  • The European Academy of Neurology emphasizes that pyramidal weakness must be distinguished from extrapyramidal dysfunction, as they represent different motor systems with different underlying pathophysiology 4
  • It is critical to avoid confusing extrapyramidal rigidity with pyramidal spasticity, as rigidity is "lead-pipe" or "cogwheel" in quality and affects agonist-antagonist muscle pairs equally, whereas spasticity is velocity-dependent and affects specific muscle groups in the characteristic pyramidal pattern 1, 2, 4